e-VIS provides a secure, straightforward and supportive e-verification system that prevents falsified medicines from reaching the patient via pharmacies or healthcare.
e-VIS provides a Swedish e-verification system that prevents falsified medicines from reaching patients via pharmacies or healthcare. The regulation requires that any organisation handling or dispensing medicines to patients must be registered with the system. In Sweden, falsified medicines aren’t currently a problem, and confidence in medicine is high. By guaranteeing a safe medicine supply chain from production to patient, we can make sure this remains true. The e-VIS system helps ensure that every patient in Sweden can be confident the medicine they receive is authentic. e-VIS (e-Verification in Sweden) is supported by industry organisations for research-based pharmaceutical companies, generic pharmaceutical companies, parallel importers, pharmaceutical wholesalers, and pharmacy companies.
e-VIS is a non-profit association that was established in 2016 in accordance with Commission Delegated Regulation (EU) 2016/161 to run the Swedish part of the European e-verification system.
The Board of Directors runs operations at e-VIS, headed by Chairman of the Board Kenneth Nyblom, Swedish Generic Medicines and Biosimilars Association
the Swedish trade Association for the research-based pharmaceutical industry
the Swedish Generic Medicines and Biosimilars Association
the Swedish Association of Pharma Traders
the Swedish Association of Pharmaceutical Wholesalers
the Swedish Pharmacy Association
The Board of Directors consists of
Kenneth Nyblom, Swedish Generic Medicines and Biosimilars Association, chairman
Andreas Roslund, Swedish Association of Pharma Traders
Johan Färnstrand, Swedish Association research-based pharmaceutical industry
Nicklas Widding, Swedish Association of Pharmaceutical Wholesalers
Johan Wallér, Swedish Pharmacy Association
Kristina von Sydow
Catarina Arbestål Bergkvist